
    
      Data on patients will be collected from the date when patient consent was obtained, during
      treatment with LutatheraÂ® and for a follow-up period until end of study (EOS), defined as the
      time when the last enrolled patient has completed 36 months of assessments (unless early
      termination) after enrolment. Data will be collected in accordance with routine clinical
      visits.

      The study duration will be 48 months in total: 12 months recruitment and 36 of follow-up from
      the last patient in.
    
  